Tendencias Ahora
Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.
¿Ya eres miembro? Iniciar sesión
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class ant... Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. Mostrar más
Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
---|---|---|---|---|---|---|---|---|
1 | -0.3024 | -30.7192198293 | 0.9844 | 0.987899 | 0.6733 | 352106 | 0.77596543 | CS |
4 | -0.217 | -24.1379310345 | 0.899 | 1.03 | 0.6733 | 309389 | 0.86636036 | CS |
12 | -0.318 | -31.8 | 1 | 1.33 | 0.6733 | 479410 | 0.9885944 | CS |
26 | -0.498 | -42.2033898305 | 1.18 | 1.41 | 0.6733 | 351965 | 1.04562132 | CS |
52 | -2.918 | -81.0555555556 | 3.6 | 21.6 | 0.6733 | 18193921 | 9.16605858 | CS |
156 | -2114.318 | -99.9677541371 | 2115 | 3667.5 | 0.6733 | 9332268 | 196.17069753 | CS |
260 | -2789.318 | -99.9755555556 | 2790 | 20113.2 | 0.6733 | 10676525 | 3712.95094062 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones